Related references
Note: Only part of the references are listed.Expression, purification, crystallization and initial X-ray diffraction analysis of thiol peroxidase from Yersinia pseudotuberculosis
Mads Gabrielsen et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2010)
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia
Markus K. Dahlgren et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Statistical Molecular Design of Balanced Compound Libraries for QSAR Modeling
A. Linusson et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Antivirulence drugs to target bacterial secretion systems
Christian Baron
CURRENT OPINION IN MICROBIOLOGY (2010)
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae
Hencelyn Chu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Thiol Peroxidase Protects Salmonella enterica from Hydrogen Peroxide Stress In Vitro and Facilitates Intracellular Growth
Sarah A. Horst et al.
JOURNAL OF BACTERIOLOGY (2010)
Synthesis of 2-(2-Aminopyrimidine)-2,2-difluoroethanols as Potential Bioisosters of Salicylidene Acylhydrazides
Markus K. Dahlgren et al.
MOLECULES (2010)
Synthesis of [4-(2-Hydroxyphenyl)thiazol-2-yl]methanones as Potential Bioisosteres of Salicylidene Acylhydrazides
J. Mikael Hillgren et al.
MOLECULES (2010)
Anti-virulence strategies to combat bacteria-mediated disease
David A. Rasko et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Structure-based discovery of antibacterial drugs
Katie J. Simmons et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Using Small Molecules To Dissect Mechanisms of Microbial Pathogenesis
Aaron W. Puri et al.
ACS CHEMICAL BIOLOGY (2009)
Designing Multiple Ligands - Medicinal Chemistry Strategies and Challenges
Richard Morphy et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Characterization of the Effects of Salicylidene Acylhydrazide Compounds on Type III Secretion in Escherichia coli O157:H7
Jai J. Tree et al.
INFECTION AND IMMUNITY (2009)
Small-Molecule Type III Secretion System Inhibitors Block Assembly of the Shigella Type III Secreton
Andreas K. J. Veenendaal et al.
JOURNAL OF BACTERIOLOGY (2009)
Structural Changes Common to Catalysis in the Tpx Peroxiredoxin Subfamily
Andrea Hall et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Identification of the cellular targets of bioactive small organic molecules using affinity reagents
Benjamin J. Leslie et al.
CHEMICAL SOCIETY REVIEWS (2008)
Antivirulence as a new antibacterial approach for chemotherapy
Sonia Escaich
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Novel strategies to combat bacterial virulence
Susan V. Lynch et al.
CURRENT OPINION IN CRITICAL CARE (2008)
Mapping short DNA sequencing reads and calling variants using mapping quality scores
Heng Li et al.
GENOME RESEARCH (2008)
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria
P. Keyser et al.
JOURNAL OF INTERNAL MEDICINE (2008)
The biology and future prospects of antivirulence therapies
Lynette Cegelski et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Design, synthesis, and Multivariate quantitative structure-activity relationship of Salicylanilides-Potent inhibitors of type III secretion in Yersinia
Markus K. Dahlgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Inhibitors of type III secretion in Yersinia:: Design, synthesis and multivariate QSAR of 2-arvisulfonylamino-benzanilides
Anna M. Kauppi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Target deconvolution strategies in drug discovery
Georg C. Terstappen et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Type III secretion systems and disease
Bryan Coburn et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium
Aurel Negrea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Reversal of the antichlaraydial activity of putative type III secretion inhibitors by iron
Anatoly Slepenkin et al.
INFECTION AND IMMUNITY (2007)
Inhibition of type III secretion in Salmonella enterica serovar typhimurium by small-molecule inhibitors
Debra L. Hudson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Analysis of the expression, regulation and export of NleA-E in Escherichia coli O157: H7
Andrew J. Roe et al.
MICROBIOLOGY-SGM (2007)
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
Leslie Bailey et al.
FEBS LETTERS (2007)
Detecting protein-protein interactions by far western blotting
Yuliang Wu et al.
NATURE PROTOCOLS (2007)
Targeting virulence: a new paradigm for antimicrobial therapy
Anne E. Clatworthy et al.
NATURE CHEMICAL BIOLOGY (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
Sandra Muschiol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle
K. Wolf et al.
MOLECULAR MICROBIOLOGY (2006)
The GrlR-GrlA regulatory system coordinately controls the expression of flagellar and LEE-encoded type III protein secretion systems in enterohemorrhagic Escherichia coli
Sunao Iyoda et al.
JOURNAL OF BACTERIOLOGY (2006)
Chemical biology and bacteria: not simply a matter of life or death
Deborah T. Hung et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
WrbA from Escherichia coli and Archaeoglobus fulgidus is an NAD(P)H:Quinone oxidoreductase
Eric V. Patridge et al.
JOURNAL OF BACTERIOLOGY (2006)
Antibacterial drug discovery and structure-based design
John J. Barker
DRUG DISCOVERY TODAY (2006)
Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa
A Rietsch et al.
MOLECULAR MICROBIOLOGY (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract
MC Lane et al.
INFECTION AND IMMUNITY (2005)
Differential roles of the universal stress proteins of Escherichia coli in oxidative stress resistance, adhesion, and motility
L Nachin et al.
JOURNAL OF BACTERIOLOGY (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Small-molecule inhibitors specifically targeting type III secretion
R Nordfelth et al.
INFECTION AND IMMUNITY (2005)
Catalytic mechanism of thiol peroxidase from Escherichia coli -: Sulfenic acid formation and overoxidation of essential CYS61
LMS Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Targeting bacterial virulence:: Inhibitors of type III secretion in Yersinia
AM Kauppi et al.
CHEMISTRY & BIOLOGY (2003)
Regulation, secretion and activity of type III-secreted proteins of enterohaemorrhagic Escherichia coli O157
AJ Roe et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling
P Schuck
BIOPHYSICAL JOURNAL (2000)
Share Paper
